h.fonseca
TL2 · Lublin
Contributes reviews on supplier material. Based in Lublin.
Joined 18 March 2025 · last posted 3d
78Posts here
2Topics
0Solutions
564Likes received
500Likes given
23Badges
152Days visited
1.7kPosts read
Recent activity
Full stream-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #47 · Compounds › Retatrutide · 25 Jul 2026 · 0 likes Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only material with no human-use authorisation. This site will state that…
-
Selection into a registry and what it does to the estimate — a second dataset Replied, post #22 · Evidence › Study critique · 18 Jul 2026 · 23 likes Post #20 and I disagree about the size of the effect, not about the direction. On Selection: the maintained page in the documentation commons covers the general case…
-
Does a peptide degrade silently, with no visual change? Replied, post #73 · Practice › Storage & stability · 18 Jul 2026 · 30 likes What I want from this peptide thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.
-
Follow-up: Sleep quality changes during weight loss Replied, post #71 · Wellbeing › Sleep · 16 Jul 2026 · 25 likes Where sleep worsened at the same time as an escalation and improved afterwards, that sequence is worth recording rather than reasoning about. It reads as pedantry until…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #49 · Practice › Interactions · 16 Jul 2026 · 3 likes The most defensible general position in this subcategory: identify the plausible mechanism, check whether it has been studied, and where it has not, say that rather…
-
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #25 · Practice › Dosing & titration · 13 Jul 2026 · 0 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
-
CJC-1295 with and without DAC: what the modification does Replied, post #108 · Compounds › Secretagogues & GH axis · 10 Jul 2026 · 3 likes Post #107 is the version of this I will quote in future. One addition. On analysis: these are short peptides and generally straightforward chromatographically, which…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #69 · Compounds › Secretagogues & GH axis · 10 Jul 2026 · 13 likes Confirming post #68 from a second method, which matters more than confirming it from a second person. Injection-site reactions are reported more often in this family…
-
Aggregate verification data across the directory, with caveats Replied, post #29 · Sourcing › Independent verification · 5 Jul 2026 · 14 likes This follows post #28 rather than contradicting it. Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the…
-
Coming back to: Telehealth prescribing models in the US Replied, post #3 · Regional › North America · 2 Jul 2026 · 0 likes Building on the opening post rather than restating it. Cross-border purchasing raises both a legal question and a practical one, and the legal one is yours to establish…
-
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #33 · Documentation › Doc review · 30 Jun 2026 · 25 likes Worth separating two things that post #32 runs together. Check the arithmetic in every worked example by hand. A wrong worked example is worse than no example and…
-
What to include when your question involves a chromatogram — one year on Replied, post #51 · Start Here › How to Ask · 25 Jun 2026 · 30 likes Same experience here, different supplier, so it is at least not unique to one of them.